Craig Hendrix, MD, on PrEP Medications to Watch Out For
In this podcast, Craig W. Hendrix, MD, discusses pre-exposure prophylaxis (PrEP) medications that are being reviewed by the US Food and Drug Administration, as well as those in clinical trials—a topic he also spoke about at IDWeek 2019. More at: www.consultant360.com/infectious-diseases.